QSI Quantum-Si Incorporated Class A Common Stock
XNAS
1.20
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $0.69 – $2.44
- YTD
- +3.60%
- IV Rank (30D)
- 10.88
- Straddle Price
- $0.38
- P/C Vol Ratio
- 0.28
- Market Cap
- $0.3B
- Open
- $1.17
- Day Range
- $1.15 – $1.21
- Volume
- 2,199,243
- Prev Close
- $1.23
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 2.14 |
| Cost of Equity (CAPM) | 16.92% (VRP-adj) |
| WACC | 16.86% |
| Volatility Risk Premium | +110.4pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -10.0% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $-0.1B |
| Return on Equity (TTM) | -54.7% |
| Book / Price | 80.9% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 40.0% |
| FCF Margin (TTM) | -5058.7% |
| Debt / Equity | 0.00 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $0.94 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $1.20 |
| Bollinger Width / SMA20 | 6144.2% (drives anchor stability) |
| Net Debt | $-0.0B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | median 22.4× · 3 peers |
| Peer P/B | $2.44 | 50% | median 2.5× · 4 peers |
| Peer P/S | $0.03 | 50% | median 3.8× · 4 peers |
| Market Anchor (SMA50) | $0.94 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $1.20 | 0% | 5 strikes · skew -0.41 |
- Industry (SIC)
- MEASURING & CONTROLLING DEVICES, NEC (3829) · industry map
- Exchange
- XNAS
- Market Cap
- $0.3B
- Employees
- 145
- List Date
- 2021-06-11
- CIK
- 0001816431
- Next Earnings
- 2026-11-05 (After-Close)
- EPS Forecast
- ($0.13) (1 est.)
- Headquarters
- Branford, CT
- Homepage
- https://www.quantum-si.com
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -41.73% | 20.65% | -23.15% | -53.52% | -2.59% | -20.07% |
| Feb | -- | -13.69% | -16.13% | 5.70% | -24.18% | -13.05% | -12.27% |
| Mar | -- | -0.85% | -1.68% | 6.49% | -7.69% | -17.08% | -4.16% |
| Apr | -- | -10.61% | -15.03% | -12.97% | -5.00% | 31.17% | -2.49% |
| May | -- | -6.39% | 3.42% | -15.56% | 44.83% | 24.19% | 10.10% |
| Jun | 25.74% | -45.79% | 16.23% | -30.00% | 16.67% | -25.00% | -7.02% |
| Jul | -21.89% | 35.42% | 117.32% | 16.65% | -22.11% | -23.50% | 16.98% |
| Aug | 12.37% | -2.80% | -36.93% | -4.26% | -23.29% | 2.67% | -8.71% |
| Sep | -14.55% | -13.79% | -29.96% | -1.98% | 30.56% | 41.29% | 1.93% |
| Oct | -4.39% | 9.78% | -23.57% | -16.55% | 47.26% | -15.73%* | -0.53% |
| Nov | -23.31% | -19.87% | 35.29% | 62.72% | -29.50% | -- | 5.07% |
| Dec | 27.35% | -26.80% | 15.52% | 136.84% | -14.73% | -- | 27.64% |
| Total | -11.94% | -83.47% | 16.53% | 56.66% | -63.94% | -19.76% | -17.65% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary Overall Assessment: NEUTRAL (Confidence Level: 6/10) Key Drivers: Technical indicators suggest a range-bound market, while news sentiment is mixed. Primary Risks: High volatility and potential for sharp price movements.
Investment Thesis: QSI's recent price action is influenced by its beta value (>3.5), indicating high volatility. The stock has been trading in a narrow range, with support from the 20-day SMA and resistance near the upper Bollinger Band. The options market is pricing in a significant move ($3.25) by expiration.
Recent News Sentiment Impact: The recent news headlines are mixed, with some articles highlighting negative sentiment (Why Quantum-Si Stock Flopped on Friday) and others emphasizing positive trends (Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback).
Technical Analysis
- Trend Direction: Short-term: Range-bound; Medium-term: Uptrend; Long-term: Trendless
- Support/Resistance Levels: SMA 20 ($0.77), Upper Bollinger Band ($0.84)
- Momentum Signals:
- RSI: Neutral (40.29) - no clear buy or sell signal
- MACD: Bearish - histogram below zero line (-0.03)
- Bollinger Bands: Neutral - price near the middle band
- Volume Analysis: Volume has been declining, with a Rate of Change indicator reading -68.43%
News & Sentiment Analysis
- Recent Headlines Summary: Mixed sentiment headlines, with some emphasizing negative and others positive trends.
- Sentiment Assessment: Negative (Why Quantum-Si Stock Flopped on Friday) and Positive (Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback)
- Catalyst Identification: Earnings announcements or regulatory changes could impact the stock's price action.
Risk & Volatility Assessment
- Beta Interpretation: High risk (>3.5) - stock moves more than market
- Volatility Regime: High volatility (0.91) - potential for sharp price movements
- Options Market Signals: IV rank: Medium; Put/Call Volume Ratio: 0.22 (Bullish sentiment)
- Downside Protection: Support levels include SMA 20 ($0.77)
Market Context & Positioning
- Sector Performance: QSI's sector, Technology, has been performing well recently.
- Institutional Activity: Institutional investors have been buying the stock, with a volume rate of change indicator reading -68.43%.
- Correlation Analysis: The stock moves in tandem with market indices (R-squared interpretation: 0.51).
- Relative Valuation: QSI is relatively cheap compared to its peers and market.
Key Levels & Action Items
- Critical Price Levels: SMA 20 ($0.77), Upper Bollinger Band ($0.84)
- Breakout/Breakdown Levels: Technical levels that could trigger significant moves: $0.70 (lower Bollinger Band) and $1.05 (upper SMA 200)
- Time-Sensitive Catalysts: Earnings announcements or regulatory changes could impact the stock's price action.
- Risk Management: Set stop-loss levels near the lower Bollinger Band ($0.70) to manage risk.
Recommendations:
- Monitor the stock's price action and technical indicators for signs of a breakout or breakdown.
- Consider buying the stock if it breaks above the upper Bollinger Band ($0.84) or selling if it falls below the lower Bollinger Band ($0.70).
- Keep an eye on earnings announcements and regulatory changes, as these could impact the stock's price action.
Data Quality Flags:
- No key data sources are missing.
- Unusual technical readings may indicate data issues.
- The news sentiment is mixed, but there is no strong contradiction between technical signals.
- The data recency and market hours considerations are not a concern for this analysis.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-08-16 | After-Close | 11.69% | 0.12% | 0.01x | Within |
| 2021-11-10 | After-Close | 9.77% | 2.47% | 0.25x | Within |
| 2022-02-28 | After-Close | 27.64% | 13.46% | 0.49x | Within |
| 2022-05-09 | After-Close | 44.41% | 3.44% | 0.08x | Within |
| 2022-08-08 | After-Close | 24.49% | 9.34% | 0.38x | Within |
| 2022-11-07 | After-Close | 20.95% | 1.98% | 0.09x | Within |
| 2023-05-11 | After-Close | 59.09% | 8.44% | 0.14x | Within |
| 2023-08-07 | After-Close | 18.70% | 10.87% | 0.58x | Within |
| 2023-11-09 | After-Close | 15.79% | 6.77% | 0.43x | Within |
| 2024-02-29 | After-Close | 23.95% | 10.78% | 0.45x | Within |
| 2024-05-09 | After-Close | 22.40% | 7.10% | 0.32x | Within |
| 2024-08-07 | After-Close | 551.83% | 3.35% | 0.01x | Within |
| 2024-11-12 | After-Close | 270.86% | 2.06% | 0.01x | Within |
| 2025-03-03 | After-Close | 23.08% | 6.15% | 0.27x | Within |
| 2025-05-15 | After-Close | 11.82% | 0.00% | 0.00x | Within |
| 2025-08-05 | After-Close | 13.89% | 4.86% | 0.35x | Within |
| 2025-11-05 | After-Close | 19.44% | 8.33% | 0.43x | Within |
| 2026-03-03 | After-Close | 18.46% | 4.01% | 0.22x | Within |
| 2026-05-07 | After-Close | 15.30% | 7.55% | 0.49x | Within |
| 2026-08-13 | After-Close | 91.77% | 6.35% | 0.07x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
QSI Options Activity & IV Rank
QSI IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 17th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
High volatility - stock moves more than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $2.8M | #2398 of 3716 | new | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $490K | #2613 of 3138 | +369.8% | 13F | |
| Citadel Hedge fund Ken Griffin | $39K | #6064 of 6285 | +185.2% | 13F | |
| Point72 Hedge fund Steve Cohen | $35K | #1892 of 1945 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
QSI Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Wolverine Trading, LLC Custodian | $281.34K | 34.58% | 2025-09-30 |
| 2 | Jane Street Group, LLC Custodian | $218.86K | 26.90% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $160.19K | 19.69% | 2026-06-30 |
| 4 | Susquehanna International Group, LLP Custodian | $153.26K | 18.84% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $221.16K | 55.51% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $95.23K | 23.90% | 2026-06-30 |
| 3 | Wolverine Trading, LLC Custodian | $52.12K | 13.08% | 2025-09-30 |
| 4 | Jane Street Group, LLC Custodian | $29.91K | 7.51% | 2026-06-30 |
QSI Insider Trading (Form 4)
Latest: 2026-09-23| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Christian LaPointe | GC & Corp. Secretary | Sell (S) | −14,516 | $0.76 | -$11.0K | EDGAR |
| 2026-09-23 | Jeffry R. Keyes | Chief Financial Officer | Sell (S) | −7,665 | $0.76 | -$5.8K | EDGAR |
| 2026-09-23 | Jeffrey Alan Hawkins | President & CEO | Sell (S) | −29,852 | $0.76 | -$22.6K | EDGAR |
| 2026-06-24 | Jeffrey Alan Hawkins | President & CEO | Sell (S) | −22,621 | $0.93 | -$21.0K | EDGAR |
| 2026-06-24 | Christian LaPointe | GC & Corp. Secretary | Sell (S) | −15,588 | $0.93 | -$14.5K | EDGAR |
| 2026-06-24 | Jeffry R. Keyes | Chief Financial Officer | Sell (S) | −8,233 | $0.93 | -$7.6K | EDGAR |
| 2026-06-24 | John S. Vieceli | Chief Product Officer | Sell (S) | −30,223 | $0.93 | -$28.1K | EDGAR |
| 2026-05-20 | Paula Dowdy | Director | Award (A) | — | — | EDGAR | |
| 2026-05-20 | Amir Jafri | Director | Award (A) | — | — | EDGAR | |
| 2026-05-20 | Kevin Rakin | Director | Award (A) | — | — | EDGAR | |
| 2026-05-20 | John P. Kenny | Director | Award (A) | — | — | EDGAR | |
| 2026-05-20 | Charles R. Kummeth | Director | Award (A) | — | — | EDGAR | |
| 2026-05-20 | Brigid Makes | Director | Award (A) | — | — | EDGAR | |
| 2026-05-20 | Ruth A Fattori | Director | Award (A) | — | — | EDGAR | |
| 2026-05-20 | Jonathan M Rothberg | Director | Award (A) | — | — | EDGAR |
QSI Insider Holdings
14 insiders · @ $1.20| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jonathan M Rothberg | Director | 20,512,193 | $24.51M | -$11.72M | 10 | 2026-05-20 |
| 2 | Jeffrey Alan Hawkins | President & CEO | 3,649,659 | $4.36M | -$323.7K | 12 | 2026-09-23 |
| 3 | Jeffry R. Keyes | Chief Financial Officer | 1,716,684 | $2.05M | -$64.7K | 13 | 2026-09-23 |
| 4 | Kevin Rakin | Director | 1,220,512 | $1.46M | -$191.2K | 8 | 2026-05-20 |
| 5 | Christian LaPointe | GC & Corp. Secretary | 1,172,634 | $1.40M | -$37.6K | 16 | 2026-09-23 |
| 6 | John S. Vieceli | Chief Product Officer | 1,140,434 | $1.36M | -$154.0K | 9 | 2026-06-24 |
| 7 | Charles R. Kummeth | Director | 855,000 | $1.02M | $459.8K | 5 | 2026-05-20 |
| 8 | Todd C. Bennett | Chief Commercial Officer | 700,003 | $836.5K | -$61.3K | 2 | 2025-09-24 |
| 9 | Paula Dowdy | Director | 269,107 | $321.6K | $104.5K | 5 | 2026-05-20 |
| 10 | Ruth A Fattori | Director | 170,512 | $203.8K | $0 | 6 | 2026-05-20 |
QSI Board & Officers
As of SEC filings through Sep 23, 2026Directors 10
- Kevin Rakin · since Sep 3, 2020
- Brigid Makes · since Jun 10, 2021
- Jonathan M Rothberg · since Jun 10, 2021
- Ruth A Fattori · since Jun 10, 2021
- Jeffrey Alan Hawkins · since Oct 10, 2022
- Scott Mendel · since May 11, 2023
- John P. Kenny · since May 19, 2023
- Amir Jafri · since Sep 22, 2023
- Paula Dowdy · since Mar 21, 2024
- Charles R. Kummeth · since May 27, 2024
Officers 5
- Jeffrey Alan Hawkins · President & CEO · listed since Mar 2024
- Jeffry R. Keyes · Chief Financial Officer · since May 15, 2023
- John S. Vieceli · Chief Product Officer · since Aug 2, 2024
- Todd C. Bennett · Chief Commercial Officer · since Sep 17, 2024
- Christian LaPointe · GC & Corp. Secretary · listed since Jun 2025
10% owners 1
- Jonathan M Rothberg · since Jun 10, 2021
Changes in the last 10 years (49)
| Jun 24, 2025 | Christian LaPointe listed as GC & Corp. Secretary (previously General Counsel & Corp. Secr.) in SEC filings |
| Sep 17, 2024 | Todd C. Bennett became Chief Commercial Officer |
| Aug 21, 2024 | The company announced the departure of Grace Johnston as Chief Commercial Officer in an SEC filing |
| Aug 2, 2024 | John S. Vieceli became Chief Product Officer |
| May 27, 2024 | Charles R. Kummeth became a director |
| Mar 21, 2024 | Paula Dowdy became a director |
| Mar 18, 2024 | Jeffrey Alan Hawkins listed as President & CEO (previously Chief Executive Officer) in SEC filings |
| Sep 22, 2023 | Amir Jafri became a director |
| Aug 26, 2023 | The company announced the departure of Patrick Schneider as President and COO in an SEC filing |
| Jun 16, 2023 | The company announced the departure of Michael P McKenna as EVP, Product Development & Ops in an SEC filing |
| May 19, 2023 | John P. Kenny became a director |
| May 15, 2023 | Jeffry R. Keyes became Chief Financial Officer |
| May 11, 2023 | Scott Mendel became a director |
| Apr 27, 2023 | The company announced the departure of Claudia Drayton as Chief Financial Officer in an SEC filing |
| Dec 21, 2022 | Grace Johnston became Chief Commercial Officer |
| Oct 10, 2022 | Jeffrey Alan Hawkins became a director |
| Oct 10, 2022 | Jeffrey Alan Hawkins became Chief Executive Officer |
| Oct 2, 2022 | The company announced the departure of Jonathan M Rothberg as Interim CEO in an SEC filing |
| Jun 15, 2022 | Vikram Bajaj became a director |
| Jun 15, 2022 | Michael P McKenna listed as EVP, Product Development & Ops (previously President and COO) in SEC filings |
| Jun 15, 2022 | Matthew Dyer reported in an SEC filing no longer being Chief Business Officer |
| May 13, 2022 | Jonathan M Rothberg first listed as Interim CEO in an SEC filing |
| May 9, 2022 | Patrick Schneider became President and COO |
| Feb 8, 2022 | The company announced the departure of John VIII Stark from the board in an SEC filing |
| Feb 8, 2022 | The company announced the departure of John VIII Stark as Chief Executive Officer in an SEC filing |
| Jun 15, 2021 | Kevin Rakin no longer listed as Chairman and CEO in SEC filings |
| Jun 10, 2021 | Ruth A Fattori became a director |
| Jun 10, 2021 | Michael P McKenna became President and COO |
| Jun 10, 2021 | Michael Mina became a director |
| Jun 10, 2021 | Matthew Dyer became Chief Business Officer |
| Jun 10, 2021 | Marijn E Dekkers became a director |
| Jun 10, 2021 | Jonathan M Rothberg became a director |
| Jun 10, 2021 | Jonathan M Rothberg became a 10% owner |
| Jun 10, 2021 | John VIII Stark became a director |
| Jun 10, 2021 | John VIII Stark became Chief Executive Officer |
| Jun 10, 2021 | James B. Tananbaum became a director |
| Jun 10, 2021 | Claudia Drayton became Chief Financial Officer |
| Jun 10, 2021 | Christian LaPointe became General Counsel & Corp. Secr. |
| Jun 10, 2021 | Brigid Makes became a director |
| Jun 10, 2021 | 4C Holdings I, LLC became a 10% owner |
| Jun 10, 2021 | 2012 JMR Trust Common LLC became a 10% owner |
| Sep 3, 2020 | Robert Taub became a director |
| Sep 3, 2020 | Matt Zuga became a director |
| Sep 3, 2020 | Matt Zuga became a 10% owner |
| Sep 3, 2020 | Kevin Rakin became a director |
| Sep 3, 2020 | Kevin Rakin became Chairman and CEO |
| Sep 3, 2020 | HighCape Capital Acquisition LLC became a director |
| Sep 3, 2020 | David Colpman became a director |
| Sep 3, 2020 | Antony Loebel became a director |
- Prev
- 1
Not reported recently (11)
- Michael Mina · Last reported as a director in an SEC filing dated May 16, 2023
- Vikram Bajaj · Last reported as a director in an SEC filing dated Jun 21, 2022
- Marijn E Dekkers · Last reported as a director in an SEC filing dated May 13, 2022
- James B. Tananbaum · Last reported as a director in an SEC filing dated Jun 14, 2021
- 4C Holdings I, LLC · Last reported as a 10% owner in an SEC filing dated Jun 14, 2021
- 2012 JMR Trust Common LLC · Last reported as a 10% owner in an SEC filing dated Jun 14, 2021
- HighCape Capital Acquisition LLC · Last reported as a director in an SEC filing dated Sep 3, 2020
- Matt Zuga · Last reported as a director in an SEC filing dated Sep 3, 2020
- David Colpman · Last reported as a director in an SEC filing dated Sep 3, 2020
- Robert Taub · Last reported as a director in an SEC filing dated Sep 3, 2020
- Antony Loebel · Last reported as a director in an SEC filing dated Sep 3, 2020
QSI Proposed Insider Sales (Form 144)
Latest: 2026-09-23What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-09-23 | LaPointe Christian | Officer | 14,516 | $11.0K | 2026-09-21 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-09-23 | Keyes Jeffry R. | Officer | 7,665 | $5.8K | 2026-09-21 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-09-23 | Hawkins Jeffrey Alan | Officer, Director | 29,852 | $22.6K | 2026-09-21 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-06-24 | Vieceli John S. | Officer | 30,223 | $28.1K | 2026-06-22 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-06-24 | LaPointe Christian | Officer | 15,588 | $14.5K | 2026-06-22 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-06-24 | Keyes Jeffry R. | Officer | 8,233 | $7.6K | 2026-06-22 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-06-24 | Hawkins Jeffrey Alan | Officer, Director | 22,621 | $21.0K | 2026-06-22 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-04-22 | Keyes Jeffry R. | Officer | 74,763 | $74.8K | 2026-04-20 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-04-22 | Hawkins Jeffrey Alan | Officer, Director | 167,424 | $167.5K | 2026-04-20 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| 2026-03-24 | Vieceli John S. | Officer | 21,997 | $18.4K | 2026-03-20 | Morgan Stanley Smith Barney LLC | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $5.7M | — | 2026-09-30 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $2.2M | — | 2026-09-30 |
| 3 | IBB iShares Biotechnology ETF | iShares (BlackRock) | 0.01% | $1.5M | $11.0B | 2026-10-20 |
| 4 | VHT Vanguard Health Care ETF | Vanguard | 0.00% | $539,006 | — | 2026-09-30 |
| 5 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $505,052 | $97.4B | 2026-10-20 |
| 6 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.01% | $303,017 | — | 2026-07-31 |
| 7 | IBBQ Invesco Nasdaq Biotechnology ETF | Nport | 0.02% | $12,262 | — | 2026-05-31 |
| 8 | BIB ProShares Ultra NASDAQ Biotechnology | ProShares | 0.01% | $9,401 | — | 2026-10-21 |
| 9 | MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF | Nport | 0.00% | $5,129 | — | 2026-05-31 |
| 10 | ARKG ARK Genomic Revolution ETF | ARK Invest | 0.40% | — | — | 2026-10-21 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $258.00K | $-21.67M | $-0.10 | $-25.64M |
| Q4 '25 | 2025-12-31 | $451.00K | $-17.61M | $-0.07 | $-16.35M |
| Q3 '25 | 2025-09-30 | $552.00K | $-35.70M | $-0.17 | $-32.02M |
| Q2 '25 | 2025-06-30 | $591.00K | $-28.84M | $-0.16 | $-20.20M |
| Q1 '25 | 2025-03-31 | $842.00K | $-19.19M | $-0.11 | $-26.15M |
| Q4 '24 | 2024-12-31 | $1.19M | $-33.12M | $-0.23 | $-22.88M |
| Q3 '24 | 2024-09-30 | $787.00K | $-25.31M | $-0.18 | $-23.15M |
| Q2 '24 | 2024-06-30 | $622.00K | $-23.10M | $-0.16 | $-18.55M |
| Q1 '24 | 2024-03-31 | $457.00K | $-19.47M | $-0.14 | $-23.21M |
| Q4 '23 | 2023-12-31 | $400.00K | $-22.05M | $-0.16 | $-20.97M |
| Q3 '23 | 2023-09-30 | $223.00K | $-24.73M | $-0.17 | $-21.44M |
| Q2 '23 | 2023-06-30 | $205.00K | $-25.57M | $-0.18 | $-22.93M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.